Lexeo Therapeutics, Inc. Common Stock (LXEO) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Lexeo Therapeutics, Inc. Common Stock (LXEO) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $452.3M, listed on NASDAQ, employing roughly 75 people, carrying a beta of 1.53 to the broader market. Lexeo Therapeutics, Inc. Led by R. Nolan Townsend, public since 2023-11-03.
Snapshot as of May 15, 2026.
- Spot Price
- $5.09
- Total OI
- 1.3K